FIELD: medicine.
SUBSTANCE: expression of lymphocyte markers CD4+ and CD8+ in tissue of patients with vulvar cancer is estimated by immunohistochemical method, and coefficient of ratio CD4+/CD8+ is calculated. If coefficient value equals 1 and more, development of recurrence within first two years after treatment is predicted. If value of coefficient is lower than 1, long remission is predicted.
EFFECT: application of the claimed method makes it possible to predict development of recurrence in patients with vulvar cancer after treatment.
1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR REMISSION DURATION PREDICTION IN PATIENTS WITH VULVA CANCER | 2016 |
|
RU2624508C1 |
| METHOD FOR PREDICTION OF RECURRENT CARCINOMA OF VULVA | 2013 |
|
RU2532342C1 |
| METHOD FOR PREDICTION OF ESOPHAGEAL CANCER PROGRESSION | 2016 |
|
RU2640954C1 |
| METHOD OF PREDICTION OF RECURRENT VULVAR CANCER I AND II STAGE | 2015 |
|
RU2608508C1 |
| METHOD OF PREDICTING RECURRENT SOFT TISSUE SARCOMAS | 2016 |
|
RU2625035C1 |
| METHOD FOR ONCOLOGICAL DISEASES COURSE PREDICTION | 2016 |
|
RU2622756C1 |
| METHOD FOR PREDICTING SURVIVAL RATE IN PATIENTS WITH ENDOMETRIOID CANCER OF UTERINE BODY | 2006 |
|
RU2299690C1 |
| METHOD FOR PREDICTION OF RECURRENT VULVAR CANCER | 2013 |
|
RU2517541C1 |
| METHOD FOR PREDICTING RELAPSES IN SKIN MELANOMA PATIENTS | 2004 |
|
RU2275637C2 |
| METHOD OF DETERMINING DURATION OF RECURRENCE-FREE INTERVAL IN SEROUS OVARIAN CANCER | 2015 |
|
RU2613302C1 |
